GoodRx CEO details partnership with TrumpRx
GoodRx President and CEO Wendy Barnes discusses the company's partnership with TrumpRx on 'The Claman Countdown.'
GoodRx CEO details TrumpRx partnership to lower prescription drug costs
GoodRx CEO Wendy Barnes discusses the company's partnership with TrumpRx and efforts to lower prescription drug costs on ‘The Claman Countdown.’
Strategist points to healthcare if investors want to diversify portfolio outside of AI
Empower chief investment strategist Marta Norton joins 'The Claman Countdown' to discuss the resilient consumer and how to diversify your portfolio.
AI is transforming healthcare, and the benefits are only growing: Dr. Peter Fleischut
NewYork-Presbyterian Executive Vice President Dr. Peter Fleischut discusses how AI is improving patient care, enhancing clinical decision-making, transforming anesthesia and shaping the future of medicine on 'Mornings with Maria.'
How AI could redefine healthcare by the end of the decade
IEEE's 2030 report ranks health technologies as the most transformative megatrend, driven by AI-powered personalized medicine and early diagnostics.
Johnson & Johnson commits to $55B, 4-year US investment plan
Johnson & Johnson CFO Joe Wolk discusses the company's second-quarter earnings and the performance of its medical technology unit, including Impella heart pumps, on ‘The Claman Countdown.’
FDA moves to expose hidden foreign drug factories, strengthen domestic production in sweeping rule proposal
The FDA's new website and regulatory overhaul aim to close a loophole that lets foreign factories hide raw drug materials from U.S. supply chain oversight.
Pfizer CEO on primary care, GLP-1 outlook and innovation timeline
Albert Bourla, Pfizer Chairman & CEO, discusses strong performance in primary care and the game-changing Metsera acquisition for GLP-1 set to launch by 2028 on 'Mornings with Maria.'
AI will be 'transformational' in drug development and discovery, Pfizer CEO says
Pfizer CEO Albert Bourla details $70B US investment in manufacturing and R&D, discussing oncology advancements, the GLP-1 drug race, and AI's transformative role in drug development on 'Mornings with Maria.'
Skilled trades resurgence collides with AI as manufacturers embrace emerging tech
Made by Anderson Brands co-founders Ali and Kory Anderson discuss how U.S. manufacturers are embracing artificial intelligence on ‘The Bottom Line.’
Zscaler CEO says Mythos is a ‘tailwind,’ not a threat to cybersecurity firms
Zscaler CEO Jay Chaudhry discusses the company’s recent numbers, the impact of Mythos on the cybersecurity industry and more on ‘The Claman Countdown.’
USC president warns universities cannot ignore AI revolution: ‘This technology is not going away’
University of Southern California president Beong-Soo Kim explains the university’s strategy for equipping its graduates with skills for an evolving job market on ‘The Claman Countdown.’
There's a 'huge momentum' around data centers and AI, Nano Nuclear founder says
Nano Nuclear Energy founder & chairman Jay Yu discusses the company's MOU with Supermicro to power AI data centers, highlights nuclear energy's role in space and maritime and more on 'Mornings with Maria.'
Build-A-Bear recalls 36,000 plush bears over choking hazard from detachable zipper slider on pouch
About 36,000 Build-A-Bear Heartwarming Hugs weighted plush bears are being recalled over a choking hazard involving a detachable zipper slider, CPSC says.
Trulieve CEO says medical cannabis reclassification a 'giant step forward for American healthcare'
Trulieve founder and CEO Kim Rivers discusses the impact of Trump's administration reclassifying state-licensed medical cannabis from Schedule 1 to Schedule 3 on 'Varney & Co.'
Americans paying less as Trump drug pricing push slashes GLP-1, fertility medicine costs, official says
GLP-1 drugs and fertility medications now cost about half what they did months ago, says Medicare Director Chris Klomp, crediting Trump.
Bessent offers big money to blow whistle on scams, says Biden 'gutted their fraud departments'
Treasury Secretary Scott Bessent says whistleblowers can earn up to 30% of recovered funds as the U.S. targets hundreds of billions in COVID relief fraud.
House Republicans expand Medicaid fraud probe to ten states
'The Big Money Show' panel discusses the crackdown on Medicaid fraud as the House expands its probe to ten states.
Dr. Oz launches fraud probe into New York's bloated Medicaid program
'The Big Money Show' discusses the crackdown on state healthcare fraud as CMS administrator Dr. Mehmet OZ launches a probe into New York's Medicaid program.
Trump announces launch of discount drug website: TrumpRx.gov
'The Big Money Show' discusses President Donald Trump's announcement of the TrumpRx.gov website and his efforts to lower prescription costs.